Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL

Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL

Abstract Background A novel treatment has been developed for erythropoietic protoporphyria (EPP) (a rare condition that leaves patients highly sensitive to light). To fully understand the burden of EPP and the benefit of treatment, a novel patient reported outcome (PRO) measure was developed called...

Full description

Saved in:
Bibliographic Details
Main Authors: G. Biolcatti (Author), S. Hanneken (Author), E. I. Minder (Author), N. J. Neumann (Author), J. H. P. Wilson (Author), P. J. Wolgen (Author), D. J. Wright (Author), A. J. Lloyd (Author)
Format: Book
Published: SpringerOpen, 2021-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items